Literature DB >> 2461543

Responsiveness of the ANP providing system to volume load in conscious dogs.

Y Nishida1, A Miyata, H Morita, N Uemura, K Kangawa, H Matsuo, H Hosomi.   

Abstract

We examined in detail changes in arterial plasma ANP concentration in response to volume load in conscious dogs. In a 5-min volume load experiment, 18 ml/kg of isosmotic and isooncotic 3% Dextran 40 in saline was infused over a period of 5 min. Mean left atrial pressure (MLAP) increased transiently by 7.6 +/- 0.9 mm Hg. Plasma ANP level (P-ANP) did not significantly increase. Assayed P-ANP levels were corrected for hemodilution. Corrected P-ANP (C-ANP) significantly increased from 206 +/- 17 to 348 +/- 34 pg/ml. However, the level of C-ANP did not reach a steady state. No significant linear correlation was found between increases in MLAP and normalized C-ANP. In a 45-min volume load experiment, the elevated level of MLAP caused by the 5-min volume load was maintained for 40 min by supplemental infusion. C-ANP significantly increased from 196 +/- 18 pg/ml to 435 +/- 73 ng/ml. The level of C-ANP reached a steady state. A close linear correlation was observed between increases in MLAP and normalized C-ANP. However, the peak time of C-ANP lagged 10 min behind MLAP. These results indicate that it takes 10 min for P-ANP to reach a steady state in fully responding to a volume load, and that the long-term volume load is a prerequisite to the response of the ANP providing system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2461543     DOI: 10.1007/bf00582544

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  29 in total

1.  Evidence for alpha-1 adrenergic receptor regulation of atriopeptin release from the isolated rat heart.

Authors:  M G Currie; W H Newman
Journal:  Biochem Biophys Res Commun       Date:  1986-05-29       Impact factor: 3.575

2.  Epinephrine increases plasma immunoreactive atrial natriuretic hormone levels in humans.

Authors:  J A Sanfield; Y Shenker; R J Grekin; S G Rosen
Journal:  Am J Physiol       Date:  1987-06

3.  Ser-Leu-Arg-Arg-atriopeptin III: the major circulating form of atrial peptide.

Authors:  D Schwartz; D M Geller; P T Manning; N R Siegel; K F Fok; C E Smith; P Needleman
Journal:  Science       Date:  1985-07-26       Impact factor: 47.728

4.  Atrial natriuretic factor in human blood.

Authors:  T Yamaji; M Ishibashi; F Takaku
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

5.  Release of atriopeptin in the rat by vasoconstrictors or water immersion correlates with changes in right atrial pressure.

Authors:  N Katsube; D Schwartz; P Needleman
Journal:  Biochem Biophys Res Commun       Date:  1985-12-31       Impact factor: 3.575

6.  Atrial natriuretic factor--a circulating hormone stimulated by volume loading.

Authors:  R E Lang; H Thölken; D Ganten; F C Luft; H Ruskoaho; T Unger
Journal:  Nature       Date:  1985 Mar 21-27       Impact factor: 49.962

7.  Vasopressin-stimulated release of atriopeptin: endocrine antagonists in fluid homeostasis.

Authors:  P T Manning; D Schwartz; N C Katsube; S W Holmberg; P Needleman
Journal:  Science       Date:  1985-07-26       Impact factor: 47.728

8.  Hypoxia-induced release of atrial natriuretic factor (ANF) from the isolated rat and rabbit heart.

Authors:  A J Baertschi; C Hausmaninger; R S Walsh; R M Mentzer; D A Wyatt; R A Pence
Journal:  Biochem Biophys Res Commun       Date:  1986-10-15       Impact factor: 3.575

9.  Molecular forms of atrial natriuretic polypeptides circulating in human plasma.

Authors:  A Miyata; T Toshimori; T Hashiguchi; K Kangawa; H Matsuo
Journal:  Biochem Biophys Res Commun       Date:  1987-01-30       Impact factor: 3.575

10.  Atrial natriuretic peptide in humans. Production and clearance by various tissues.

Authors:  I G Crozier; M G Nicholls; H Ikram; E A Espiner; T G Yandle; S Jans
Journal:  Hypertension       Date:  1986-06       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.